Clinical Trial Update: Hypertension Study of Ventavis® Inhalation Therapy in the Treatment of Patients With Pulmonary Arterial Hypertension (VENIS)

View source ↗

Summary

The VENIS trial evaluating Ventavis inhalation therapy for pulmonary arterial hypertension has completed. This update notes the trial status but does not provid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Ventavis (iloprost)

Snippet

Sponsor: Bayer | Conditions: Pulmonary Hypertension | Status: COMPLETED